Rebecca Kuenzler, MD
Neurology · Cleveland, OHNPI 1164463873
Payments from drug & device makers
What this record shows
This record is dominated by education: $28 of the $28 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Tanabe Pharma America, Inc.. That places this record below the midpoint for neurology clinicians in OH, where the typical reported total is $970.
Across 1 payment — averaging $28.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tanabe Pharma America, Inc.$28
Across 11 payments — averaging $22,885 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$199K
- AstraZeneca$22K
- Amylyx Pharmaceuticals, Inc.$15K
- Biohaven Pharmaceutical Holding Company Ltd.$15K
What the payments were for
- Education$28100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tanabe Pharma America, Inc. | 1 | $28 |
How this compares
$28 in reported general payments places this provider in the 10th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 78 | $1,115,987 |
| ZilbrysqZilucoplan Sodium | 20 | $729,459 |
| FirdapseAmifampridine Phosphate | 12 | $680,906 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 30 | $429,164 |
| RelyvrioSod Phenylbutyrat/Taurursodiol | 16 | $314,120 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $221,326 |
| NuedextaDextromethorphan Hbr/Quinidine | 45 | $92,477 |
| Riluzole | 153 | $27,573 |
| Pregabalin | 75 | $3,395 |
| Pyridostigmine Bromide | 39 | $2,782 |
| Azathioprine | 35 | $1,586 |
| Gabapentin | 84 | $1,410 |
| Baclofen | 73 | $1,206 |
| Atropine Sulfate | 15 | $1,114 |
| Amitriptyline Hcl | 24 | $369 |
Paid to pharmacies, not to this prescriber.
Other neurology in Cleveland
- Imad NajmCleveland$373K
- Hesham AbboudCleveland$363K
- Robert BermelCleveland$302K
- Eric BaronCleveland$297K
- Robert FoxCleveland$296K
- Aarushi SunejaCleveland$269K
- Mary WillisCleveland$254K
- Benjamin WalterCleveland$210K
- Aasef ShaikhCleveland$186K
- Maryann MaysCleveland$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.